03rd week of 2021 patent applcation highlights part 22 |
Patent application number | Title | Published |
20210017125 | Novel calcium salt polymorphs as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents | 2021-01-21 |
20210017126 | Antibacterial Agents: Arylalkylcarboxamido Phloroglucinols | 2021-01-21 |
20210017127 | COMPOUND, PHOTORESIST COMPOSITION COMPRISING SAME, PHOTORESIST PATTERN COMPRISING SAME, AND METHOD FOR MANUFACTURING PHOTORESIST PATTERN | 2021-01-21 |
20210017128 | METHOD FOR PRODUCING ORGANIC MERCAPTO COMPOUND OR INTERMEDIATE THEREOF, (POLY)THIOL COMPONENT, POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, MOLDED PRODUCT, OPTICAL MATERIAL, AND LENS | 2021-01-21 |
20210017129 | REFINED METHIONINE PRODUCTION METHOD | 2021-01-21 |
20210017130 | USE OF ISOTHIOCYANATE FUNCTIONAL SURFACTANTS AS NRF2 INDUCERS TO TREAT EPIDERMOLYSIS BULLOSA SIMPLEX AND RELATED DISEASES | 2021-01-21 |
20210017131 | P2RX7 MODULATORS IN THERAPY | 2021-01-21 |
20210017132 | NON-AGGREGATING HEPTAMETHINE CYANINE FLUOROPHORES FOR IN VIVO IMAGING | 2021-01-21 |
20210017133 | USE OF FLUORINATED DERIVATIVES OF 4-AMINOPYRIDINE IN THERAPEUTICS AND MEDICAL IMAGING | 2021-01-21 |
20210017134 | 4-(METHYLAMINOPHENOXY)PYRDIN-3-YL-BENZAMIDE DERIVATIVES FOR TREATING CANCER | 2021-01-21 |
20210017135 | 1,4-SUBSTITUTED ISOQUINOLINE INHIBITORS OF KEAP1/NRF2 PROTEIN-PROTEIN INTERACTION | 2021-01-21 |
20210017136 | HETEROCYCLIC COMPOUNDS AS PESTICIDES | 2021-01-21 |
20210017137 | SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR | 2021-01-21 |
20210017138 | An Antimicrobial Compound | 2021-01-21 |
20210017139 | INHIBITORS FOR THE B-CATENIN / T-CELL FACTOR PROTEIN-PROTEIN INTERACTION | 2021-01-21 |
20210017140 | PROTEASE INHIBITORS | 2021-01-21 |
20210017141 | BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS | 2021-01-21 |
20210017142 | PROCESS FOR THE PREPARATION OF GLYCIDOL | 2021-01-21 |
20210017143 | HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON | 2021-01-21 |
20210017144 | METHOD FOR PRODUCING SOLID DISPERSION CONTAINING NOBILETIN | 2021-01-21 |
20210017145 | PROCESS FOR PRODUCING AN EXTRACT CONTAINING TETRAHYDROCANNABINOL AND CANNABIDIOL FROM CANNABIS PLANT MATERIAL, AND CANNABIS EXTRACTS | 2021-01-21 |
20210017146 | METHOD FOR PRODUCING GLYCOLIDE | 2021-01-21 |
20210017147 | Diphenyl Substituted Thiophene-2-Amide Derivatives and Pharmaceutical Compositions Thereof Useful as Antimicrobial | 2021-01-21 |
20210017148 | CRYSTALLINE FORMS OF ARN-509, PREPARATION METHOD AND USE THEREOF | 2021-01-21 |
20210017149 | GluN2C/D Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptor | 2021-01-21 |
20210017150 | HOLOGRAPHIC IN-FIELD ILLUMINATOR | 2021-01-21 |
20210017151 | Crystalline Forms of Niraparib Tosylate | 2021-01-21 |
20210017152 | PREPARATIVE PROCESS | 2021-01-21 |
20210017153 | AHR INHIBITORS AND USES THEREOF | 2021-01-21 |
20210017154 | N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | 2021-01-21 |
20210017155 | PYRIMIDINYL TYROSINE KINASE INHIBITORS | 2021-01-21 |
20210017156 | PYRAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS | 2021-01-21 |
20210017157 | ISLET CELL MANUFACTURING COMPOSITIONS AND METHODS OF USE | 2021-01-21 |
20210017158 | NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS | 2021-01-21 |
20210017159 | 5-SUBSTITUTED DIFLUOROPIPERIDINE COMPOUNDS WITH BLOOD-BRAIN BARRIER PENETRABLE CAPABILITY | 2021-01-21 |
20210017160 | DEUTERATED sGC STIMULATORS | 2021-01-21 |
20210017161 | DEUTERATED sGC STIMULATORS | 2021-01-21 |
20210017162 | NEURITE OUTGROWTH PROMOTERS AND USES THEREOF | 2021-01-21 |
20210017163 | HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION | 2021-01-21 |
20210017164 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2021-01-21 |
20210017165 | ANTIBIOTICS EFFECTIVE FOR GRAM-NEGATIVE PATHOGENS | 2021-01-21 |
20210017166 | PHARMACOKINETICALLY IMPROVED COMPOUNDS | 2021-01-21 |
20210017167 | INHIBITORS OF LYSINE GINGIPAIN | 2021-01-21 |
20210017168 | SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | 2021-01-21 |
20210017169 | SUBSTITUTED HETEROAROMATIC PYRAZOLO-PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | 2021-01-21 |
20210017170 | PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS | 2021-01-21 |
20210017171 | AMINO ACID COMPOUNDS AND METHODS OF USE | 2021-01-21 |
20210017172 | TOLL-LIKE RECEPTOR AGONISTS | 2021-01-21 |
20210017173 | TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE | 2021-01-21 |
20210017174 | IDENTIFICATION AND USE OF ERK5 INHIBITOR | 2021-01-21 |
20210017175 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2021-01-21 |
20210017176 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | 2021-01-21 |
20210017177 | HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS | 2021-01-21 |
20210017178 | Pan-Tropic Entry nhibitors | 2021-01-21 |
20210017179 | SHORT CONJUGATED OLIGOELECTROLYTES AND USES THEREOF | 2021-01-21 |
20210017180 | PYCLEN-BASED MACROCYCLIC LIGANDS, CHELATES THEREOF AND USES THEREOF | 2021-01-21 |
20210017181 | PYRIDINE OR N,N-DIMETHYL ACETAMIDE SOLVATED SOLID STATE FORMS OF SOLVATED IDELALISIB, THEIR USE AND PREPARATION | 2021-01-21 |
20210017182 | HETEROCYCLIC INHIBITORS OF PTPN11 | 2021-01-21 |
20210017183 | TRAF 6 INHIBITORS | 2021-01-21 |
20210017184 | COMPOSITIONS FOR ACTIVATING PYRUVATE KINASE | 2021-01-21 |
20210017185 | MORPHIC FORMS OF MARIZOMIB AND USES THEREOF | 2021-01-21 |
20210017186 | SUBSTITUTED 2-PYRIDONE TRICYCLIC COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME | 2021-01-21 |
20210017187 | HETEROCYCLIC COMPOUNDS, PREPARATION METHODS THEREFOR, AND METHODS OF USES THEREOF | 2021-01-21 |
20210017188 | SOLID STATE FORMS OF RELUGOLIX | 2021-01-21 |
20210017189 | 1,4-DIPHENYL-1H-IMIDAZOLE AND 2,4-DIPHENYLTHIAZOLE DERIVATIVES AND PREPARATION METHOD THEREFOR AND USE THEREOF | 2021-01-21 |
20210017190 | THIENODIAZEPINE DERIVATIVES AND APPLICATION THEREOF | 2021-01-21 |
20210017191 | CRYSTAL OF COMPOUND HAVING JAK-INHIBITING ACTIVITY | 2021-01-21 |
20210017192 | HETEROCYCLE-SUBSTITUTED BICYCLIC AZOLE PESTICIDES | 2021-01-21 |
20210017193 | CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | 2021-01-21 |
20210017194 | CONDENSED HETEROCYCLIC COMPOUNDS AND PESTICIDES | 2021-01-21 |
20210017195 | PROCESS FOR FUNCTIONALIZATION OF ORGANO-ZINC COMPOUNDS WITH HALOSILANES USING BASIC NITROGEN CONTAINING HETEROCYCLES AND SILYL-FUNCTIONALIZED COMPOUNDS PREPARED THEREBY | 2021-01-21 |
20210017196 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | 2021-01-21 |
20210017197 | PREPARATION OF SILOXANES IN THE PRESENCE OF CATIONIC SILICON (II) COMPOUNDS | 2021-01-21 |
20210017198 | Organoamino-Functionalized Cyclic Oligosiloxanes For Deposition Of Silicon-Containing Films | 2021-01-21 |
20210017199 | POLYMER CROSSLINKING AGENT, AND HIGH MOLECULAR WEIGHT POLYMER AND COMPOSITION USING SAME | 2021-01-21 |
20210017200 | Hydrocarbyl Tin Complex with Antitumor Activity and Preparation Method Thereof | 2021-01-21 |
20210017201 | ARF6 INHIBITORS AND RELATED METHODS | 2021-01-21 |
20210017202 | SPHINGOMYELIN-DERIVED LIPID AND METHOD FOR PRODUCING SAME | 2021-01-21 |
20210017203 | Hydrocarbyl Tin Complex of Alkynyl Phosphonic Acid with Antitumor Activity and Application Thereof | 2021-01-21 |
20210017204 | SURFACE TREATMENT AGENT, SURFACE TREATMENT METHOD, AND AREA SELECTIVE DEPOSITION METHOD | 2021-01-21 |
20210017205 | Fluoro-Pyridinone Phosphates And Boronates Useful As Antibacterial Agents | 2021-01-21 |
20210017206 | PYRIDINONE AND PYRIMIDINONE PHOSPHATES AND BORONATES USEFUL AS ANTIBACTERIAL AGENTS | 2021-01-21 |
20210017207 | TETRAPHENYLPHENOXY TUNGSTEN OXO ALKYLIDENE COMPLEXES AND METHODS OF MAKING SAME AND USE THEREOF | 2021-01-21 |
20210017208 | BIOFILM INHIBITING COMPOSITIONS ENHANCING WEIGHT GAIN IN LIVESTOCK | 2021-01-21 |
20210017209 | TRANSITION METAL COMPOUND FOR OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION CATALYST INCLUDING SAME, AND POLYOLEFIN POLYMERIZED BY USING OLEFIN POLYMERIZATION CATALYST | 2021-01-21 |
20210017210 | METHODS OF RECOVERING LIGNIN AND OTHER PRODUCTS FROM BIOMASS | 2021-01-21 |
20210017211 | OLIGOSACCHARIDE C-GLYCOSIDE DERIVATIVES | 2021-01-21 |
20210017213 | Glycan Analysis and Profiling | 2021-01-21 |
20210017214 | GALNAC PHOSPHORAMIDITES, NUCLEIC ACID CONJUGATES THEREOF AND THEIR USE | 2021-01-21 |
20210017215 | E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | 2021-01-21 |
20210017216 | ADENOSINE ANALOGS AS METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER | 2021-01-21 |
20210017217 | Nucleic Acid Aptamers to Treat Histone-Induced Disease States | 2021-01-21 |
20210017218 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2021-01-21 |
20210017219 | INHIBITORS OF GLUCOCORTICOID RECEPTOR | 2021-01-21 |
20210017220 | INHIBITORS OF GLUCOCORTICOID RECEPTOR | 2021-01-21 |
20210017221 | NOVEL METHODS OF PROTEIN EVOLUTION | 2021-01-21 |
20210017222 | SELECTIVE REDUCTION OF ANTIBODIES | 2021-01-21 |
20210017223 | Separation Method | 2021-01-21 |
20210017224 | METHOD FOR THE PURIFICATION OF BIOLOGICAL MACROMOLECULAR COMPLEXES | 2021-01-21 |
20210017226 | METHOD OF GENERATING INTERACTING PEPTIDES | 2021-01-21 |